Voxel SA (Poland) (VOX) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROCE of 28.33%

High Debt Company with a Debt to Equity ratio (avg) at times

Healthy long term growth as Net Sales has grown by an annual rate of 17.22%

Positive results in Mar 25

With ROE of 26.79%, it has a fair valuation with a 4.89 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

PLN 1,281 Million (Small Cap)

P/E

18.00

Industry P/E

Dividend Yield

3.92%

Debt Equity

0.03

Return on Equity

25.52%

Price to Book

3.34

Revenue and Profits:

Net Sales:

158 Million

(Quarterly Results - Mar 2025)

Net Profit:

25 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-27.98%

6 Months

-25.86%

1 Year

-2.02%

2 Years

51.25%

3 Years

178.8%

4 Years

149.48%

5 Years

182.05%

Voxel SA (Poland) for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

17.22%

EBIT Growth (5y)

40.41%

EBIT to Interest (avg)

9.52

Debt to EBITDA (avg)

0.48

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

1.30

Tax Ratio

18.12%

Dividend Payout Ratio

52.05%

Pledged Shares

Institutional Holding

ROCE (avg)

28.33%

ROE (avg)

24.52%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.89

EV to EBIT

13.91

EV to EBITDA

9.92

EV to Capital Employed

4.56

EV to Sales

3.17

PEG Ratio

2.24

Dividend Yield

2.88%

ROCE (Latest)

32.75%

ROE (Latest)

26.79%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 45.30% vs 12.19% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 26.02% vs 63.33% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "157.80",
          "val2": "108.60",
          "chgp": "45.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.50",
          "val2": "40.70",
          "chgp": "14.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.80",
          "val2": "2.30",
          "chgp": "21.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "24.70",
          "val2": "19.60",
          "chgp": "26.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "210.70%",
          "val2": "267.90%",
          "chgp": "-5.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.71% vs 17.64% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.86% vs 48.11% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "507.80",
          "val2": "424.20",
          "chgp": "19.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "173.90",
          "val2": "149.30",
          "chgp": "16.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.50",
          "val2": "11.60",
          "chgp": "-18.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.60",
          "val2": "-0.20",
          "chgp": "3,900.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "97.70",
          "val2": "82.20",
          "chgp": "18.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "248.60%",
          "val2": "260.80%",
          "chgp": "-1.22%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

157.80

108.60

45.30%

Operating Profit (PBDIT) excl Other Income

46.50

40.70

14.25%

Interest

2.80

2.30

21.74%

Exceptional Items

-0.10

Consolidate Net Profit

24.70

19.60

26.02%

Operating Profit Margin (Excl OI)

210.70%

267.90%

-5.72%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is 45.30% vs 12.19% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 26.02% vs 63.33% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

507.80

424.20

19.71%

Operating Profit (PBDIT) excl Other Income

173.90

149.30

16.48%

Interest

9.50

11.60

-18.10%

Exceptional Items

7.60

-0.20

3,900.00%

Consolidate Net Profit

97.70

82.20

18.86%

Operating Profit Margin (Excl OI)

248.60%

260.80%

-1.22%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 19.71% vs 17.64% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 18.86% vs 48.11% in Dec 2023

All Annual Results

Company CV

About Voxel SA (Poland)

Voxel SA (Poland)

Hospital

Voxel SA is a Poland-based company active in the healthcare sector. It provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.

Company Coordinates

Company Details

Ul. Wielicka 265 , KRAKOW None : 30-663

Tel: 48 32 6060501

http://www.voxel.pl

Registrar Details